Teneovita will distribute Biocept's test services to hospitals, oncology centers, and individual medical practices throughout the country.
The test runs on Roche's LightCycler 480 instruments or Cobas z 480 analyzers.
The firm's PCR-based products for HPV-associated cancers look at DNA methylation at specific genes and include several sample preparation kits.
The contract was awarded by the UK's NHS Blood and Transplant, which is responsible for promoting and overseeing organ and blood donation.
The new guidance could benefit Hologic and Roche, both of which market molecular blood screening tests authorized by the FDA under an investigational new drug study protocol.
In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.
A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.